<DOC>
	<DOCNO>NCT01453426</DOCNO>
	<brief_summary>This open-label , parallel-group study evaluate PK , safety , tolerability two different dose regimen BG00012 24-hour period adult Chinese , Japanese , Caucasian healthy volunteer .</brief_summary>
	<brief_title>Phase 1 Study Evaluate PK , Safety , Tolerability BG00012 Chinese , Japanese , Caucasian Healthy Volunteers</brief_title>
	<detailed_description>The purpose healthy volunteer study provide pharmacokinetic safety data two different dose regimen BG00012 . The study evaluate BG00012 administered 24-hour period . The study conduct male female Chinese , Japanese , Caucasian healthy volunteer .</detailed_description>
	<mesh_term>Dimethyl Fumarate</mesh_term>
	<criteria>Must give write informed consent authorization require local law All subject must practice effective contraception study willing able continue contraception 30 day last dose study treatment . History clinically significant cardiac , endocrine , hematologic , hepatic , immunologic , metabolic , urologic , pulmonary , neurologic , dermatologic , psychiatric , renal , major disease , determine Investigator . History malignancy ( subject basal cell carcinoma completely excise prior study entry remain eligible ) History severe allergic anaphylactic reaction Known history positive test result Human Immunodeficiency Virus ( HIV ) Serious infection ( e.g. , pneumonia , septicemia ) within 2 month prior Screening . Female subject pregnant currently breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>